About GenIbet
GenIbet is a company based in Oeiras (Portugal) founded in 2006 was acquired by Recipharm in February 2022.. GenIbet offers products and services including Biologics Manufacturing, RNA Manufacturing, ATMP Fill and Finish, and Plasmid Manufacturing. GenIbet operates in a competitive market with competitors including Bionova Scientific, Avid Bioservices, Just Biotherapeutics, JHL Biotech and ProBioGen AG, among others.
- Headquarter Oeiras, Portugal
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Recipharm Ab
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GenIbet
GenIbet offers a comprehensive portfolio of products and services, including Biologics Manufacturing, RNA Manufacturing, ATMP Fill and Finish, and Plasmid Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Production of biologics for drug development and therapies
Creation of RNA therapies and lipid nanoparticles
Final processing of advanced therapy medicinal products
Production of plasmid DNA for genetic applications
Funding Insights of GenIbet
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $13,210
-
First Round
First Round
(01 Mar 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Grant - GenIbet | Valuation |
investors |
|
| Jun, 2019 | Amount | Grant - GenIbet | Valuation |
investors |
|
| May, 2017 | Amount | Grant - GenIbet | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GenIbet
GenIbet has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Recipharm and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Pharmaceutical development and manufacturing services are offered contractually.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GenIbet
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GenIbet
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genibet Comparisons
Competitors of GenIbet
GenIbet operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bionova Scientific, Avid Bioservices, Just Biotherapeutics, JHL Biotech and ProBioGen AG, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Mammalian cell culture biologics are developed through contract research services.
|
|
| domain | founded_year | HQ Location |
Drug substance development, analytical, and compliance services are provided.
|
|
| domain | founded_year | HQ Location |
Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs
|
|
| domain | founded_year | HQ Location |
Contract manufacturing solutions for biologics are provided to Asian companies.
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization focussed on therapeutic proteins/antibodies, viral vaccines and biosimilars
|
|
| domain | founded_year | HQ Location |
Biologics CDMO specializing in mammalian cell line based manufacturing
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genibet
Frequently Asked Questions about GenIbet
When was GenIbet founded?
GenIbet was founded in 2006 and raised its 1st funding round 9 years after it was founded.
Where is GenIbet located?
GenIbet is headquartered in Oeiras, Portugal.
Who is the current CEO of GenIbet?
Raquel Fortunato is the current CEO of GenIbet.
What does GenIbet do?
GenIbet was established in 2006 in Oeiras, Portugal, within the biotechnology sector. Microbial and mammalian-derived products are created through specialized services such as cell line development, process development, and analytical development. Manufacturing activities cover mammalian and insect cells, recombinant proteins, viruses, and biomass from bacteria or yeast. Operations remain focused on biopharmaceutical production and research support in Europe.
Who are the top competitors of GenIbet?
GenIbet's top competitors include Avid Bioservices, Bionova Scientific and Rentschler Biopharma.
What products or services does GenIbet offer?
GenIbet offers Biologics Manufacturing, RNA Manufacturing, ATMP Fill and Finish, and Plasmid Manufacturing.
Who are GenIbet's investors?
GenIbet has 2 investors. Key investors include Recipharm, and European Union.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.